Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  HIV Infection

  Free Subscription


3 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
6 Clin Infect Dis
7 HIV Med
6 J Acquir Immune Defic Syndr
1 J Am Acad Dermatol
1 J Clin Invest
1 J Infect Dis
1 J Med Virol
1 J Pediatr
1 J Virol
2 Lancet
1 MMWR Morb Mortal Wkly Rep
1 Nature
11 PLoS One
1 PLoS Pathog
1 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AIDS Res Hum Retroviruses

  1. RUBIN L, Neijna A, Shi Q, Hoover DR, et al
    Degree of polypharmacy and cognitive function in older women with HIV.
    AIDS Res Hum Retroviruses. 2022 Mar 31. doi: 10.1089/AID.2021.0231.
    PubMed         Abstract available

  2. RUIZ-ALGUERO M, Alejos B, Garcia Yubero C, Riera Jaume M, et al
    Use of generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection in Spain.
    AIDS Res Hum Retroviruses. 2022 Mar 31. doi: 10.1089/AID.2021.0122.
    PubMed         Abstract available

  3. KOAY WLA, Xiao J, Temprosa M, Happ LP, et al
    Outcomes of Dual Versus Triple Antiretroviral Drug Regimens Among Virally Suppressed Adults in the DC Cohort.
    AIDS Res Hum Retroviruses. 2022 Mar 23. doi: 10.1089/aid.2021.0202.
    PubMed         Abstract available

    Antimicrob Agents Chemother

  4. SONG N, Zhou X, Li D, Li X, et al
    A Proteomic Landscape of Candida albicans in the Stepwise Evolution to Fluconazole Resistance.
    Antimicrob Agents Chemother. 2022 Mar 28:e0210521. doi: 10.1128/aac.02105.
    PubMed         Abstract available

    Clin Infect Dis

  5. LEE TH, Hunt CM, Maier MM, Lowy E, et al
    Hepatitis B Virus-Related Care Quality In Patients With Hepatitis B/Hiv Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study.
    Clin Infect Dis. 2022 Mar 29. pii: 6555659. doi: 10.1093.
    PubMed         Abstract available

  6. BATEMAN M, Wolf A, Chimukangara B, Brust JCM, et al
    Adherence measured using electronic dose monitoring is associated with emergent antiretroviral resistance and poor outcomes in patients co-infected with HIV/AIDS and multidrug-resistant tuberculosis.
    Clin Infect Dis. 2022 Mar 30. pii: 6555759. doi: 10.1093.
    PubMed         Abstract available

  7. AMIN J, Vaccher S, Templeton DJ, Bavinton B B, et al
    Low prior exposure and incidence of hepatitis C in HIV negative gay and bisexual men taking PrEP: findings from the EPIC-NSW prospective implementation study.
    Clin Infect Dis. 2022 Mar 30. pii: 6555792. doi: 10.1093.
    PubMed         Abstract available

  8. NATHELLA PK, Moideen K, Viswanathan V, Sivakumar S, et al
    Heightened microbial translocation is a prognostic biomarker of recurrent tuberculosis.
    Clin Infect Dis. 2022 Mar 30. pii: 6555776. doi: 10.1093.
    PubMed         Abstract available

  9. GARRETT N, Tapley A, Andriesen J, Seocharan I, et al
    High Asymptomatic Carriage with the Omicron Variant in South Africa.
    Clin Infect Dis. 2022 Mar 30. pii: 6556153. doi: 10.1093.
    PubMed         Abstract available

  10. ANTINORI A, Cicalini S, Meschi S, Bordoni V, et al
    Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with current CD4 T-lymphocyte count.
    Clin Infect Dis. 2022 Apr 2. pii: 6562777. doi: 10.1093.
    PubMed         Abstract available

    HIV Med

  11. CROXFORD S, Emanuel E, Shah A, Chau C, et al
    Epidemiology of HIV infection and associated behaviours among people who inject drugs in England, Wales, and Northern Ireland: Nearly 40 years on.
    HIV Med. 2022 Mar 30. doi: 10.1111/hiv.13297.
    PubMed         Abstract available

  12. SHANKS G, Shah A, Williams A, Asboe D, et al
    Covid-19 First Wave Impact National Survey for HIV Clinicians by Public Health England (PHE), the British HIV Association (BHIVA) and the Children's HIV Association (CHIVA).
    HIV Med. 2022 Mar 28. doi: 10.1111/hiv.13307.
    PubMed         Abstract available

  13. SWANN SA, King EM, Cote HCF, Murray MCM, et al
    Stressing the need for validated measures of cortisol in HIV research: A scoping review.
    HIV Med. 2022 Mar 27. doi: 10.1111/hiv.13272.
    PubMed         Abstract available

  14. TEKALIGN T, Awoke N, Eshetu K, Gelaw Walle B, et al
    HIV/AIDS post-exposure prophylaxis knowledge and uptake among health professionals in Africa: Systematic review and meta-analysis.
    HIV Med. 2022 Mar 30. doi: 10.1111/hiv.13271.
    PubMed         Abstract available

  15. LUU B, Ruderman S, Nance R, Delaney JAC, et al
    Tobacco smoking and binge alcohol use are associated with incident venous thromboembolism in an HIV cohort.
    HIV Med. 2022 Mar 28. doi: 10.1111/hiv.13309.
    PubMed         Abstract available

  16. HENRIQUES BL, Cortez AL, Nunes NN, Vidal JE, et al
    Clinical outcomes of HIV-syphilis coinfection among patients with no neurological symptoms: a retrospective cohort study.
    HIV Med. 2022 Mar 27. doi: 10.1111/hiv.13306.
    PubMed         Abstract available

  17. COCKBAIN B, Whitlock G
    Immediate PrEP when accessing PEP: A service evaluation.
    HIV Med. 2022 Mar 29. doi: 10.1111/hiv.13310.
    PubMed         Abstract available

    J Acquir Immune Defic Syndr

  18. BACHA JM, Dlamini S, Anabwani F, Gwimile J, et al
    Achieving antiretroviral therapy uptake and viral suppression among children and adolescents living with HIV in the UNAIDS 90-90-90 era across six countries in Eastern and Southern Africa - lessons from the BIPAI Network.
    J Acquir Immune Defic Syndr. 2022 Apr 1. pii: 00126334-990000000-00018.
    PubMed         Abstract available

  19. SHARPLESS L, Kershaw T, Hatcher A, Alexander KA, et al
    Intimate Partner Violence (IPV) and Patient-Provider Communication about HIV Pre-Exposure Prophylaxis (PrEP): The Moderating Role of IPV-Specific Medical Mistrust.
    J Acquir Immune Defic Syndr. 2022 Apr 1. pii: 00126334-990000000-00017.
    PubMed         Abstract available

  20. PATHELA P, Qasmieh S, Gandhi M, Rozen E, et al
    Use of remnant specimens to assess use of HIV pre-exposure prophylaxis (PrEP) among populations with risk for HIV infection: A novel approach.
    J Acquir Immune Defic Syndr. 2022 Mar 31. pii: 00126334-990000000-00015.
    PubMed         Abstract available

  21. BROWNE EN, Brown ER, Palanee-Phillips T, Reddy K, et al
    Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2022 Mar 28. pii: 00126334-990000000-00014.
    PubMed         Abstract available

  22. SHAPIRO AE, Bender Ignacio RA, Whitney BM, Delaney JA, et al
    Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020.
    J Acquir Immune Defic Syndr. 2022 Apr 1. pii: 00126334-990000000-00019.
    PubMed         Abstract available

  23. SALONER R, Lobo JD, Paolillo EW, Campbell LM, et al
    Cognitive and Physiologic Reserve Independently Relate to Superior Neurocognitive Abilities in Adults Aging with HIV.
    J Acquir Immune Defic Syndr. 2022 Apr 1. pii: 00126334-990000000-00016.
    PubMed         Abstract available

    J Am Acad Dermatol

  24. SETH D, Williams VL, McMahon DE, Regan S, et al
    The role of dermatology in Kaposi sarcoma diagnosis across 3 regions in sub-Saharan Africa.
    J Am Acad Dermatol. 2021;85:1414-1417.

    J Clin Invest

  25. LEYRE L, Jones RB
    Hide and seek: for HIV-infected CD4+ T cells, playing well comes with maturity.
    J Clin Invest. 2022;132:1-4.
    PubMed         Abstract available

    J Infect Dis

  26. LOUVANTO K, Baral P, Burchell A, Ramanakumar A, et al
    Role of Human Leukocyte Antigen Allele Sharing in Human Papillomavirus Infection Transmission Among Heterosexual Couples: Findings From the Hitch Cohort Study.
    J Infect Dis. 2022 Apr 1. pii: 6562380. doi: 10.1093.
    PubMed         Abstract available

    J Med Virol

  27. FIORE BD, Andrea V, Giuseppe P, Yagai B, et al
    Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study.
    J Med Virol. 2022 Mar 31. doi: 10.1002/jmv.27754.
    PubMed         Abstract available

    J Pediatr

  28. MUSSA A, Powis KM, Lockman S, Ajibola G, et al
    Prolonged co-trimoxazole prophylaxis has no impact on child growth in the first two years of life: findings from a randomized controlled trial in Botswana.
    J Pediatr. 2022 Mar 26. pii: S0022-3476(22)00281.
    PubMed         Abstract available

    J Virol

  29. NGUYEN HT, Qualizza A, Anang S, Zhao M, et al
    Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation.
    J Virol. 2022 Mar 28:e0166821. doi: 10.1128/jvi.01668.
    PubMed         Abstract available


  30. MAYER KH, Allan-Blitz LT
    Enhancing HIV Prevention With New Modalities and Routine Sexual History Discussions.
    JAMA. 2022 Mar 28. pii: 2790710. doi: 10.1001/jama.2022.3848.


  31. KRAUSE PR, Rees H, Figueroa JP, Swaminathan S, et al
    Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply.
    Lancet. 2022;399:1225.

  32. FALLAH MP, Reinhart E
    Apartheid logic in global health.
    Lancet. 2022;399:902-903.

    MMWR Morb Mortal Wkly Rep

  33. WENG MK, Doshani M, Khan MA, Frey S, et al
    Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:477-483.
    PubMed         Abstract available


  34. DEGRACE MM, Ghedin E, Frieman MB, Krammer F, et al
    Defining the risk of SARS-CoV-2 variants on immune protection.
    Nature. 2022 Mar 31. pii: 10.1038/s41586-022-04690.
    PubMed         Abstract available

    PLoS One

  35. KITENGE MK, Laxmeshwar C, Bermudez Aza E, Ford-Kamara E, et al
    Acceptability of unsupervised peer-based distribution of HIV oral self-testing for the hard-to-reach in rural KwaZulu Natal, South Africa: Results from a demonstration study.
    PLoS One. 2022;17:e0264442.
    PubMed         Abstract available

  36. KIM JH, Jiamsakul A, Kiertiburanakul S, Huy BV, et al
    Patterns and prognosis of holding regimens for people living with HIV in Asian countries.
    PLoS One. 2022;17:e0264157.
    PubMed         Abstract available

  37. BRANAS F, Galindo MJ, Torralba M, Antela A, et al
    Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: The FUNCFRAIL cohort study (GeSIDA 9817).
    PLoS One. 2022;17:e0266191.
    PubMed         Abstract available

  38. EDWARDS RJ, Mohammed A, Lavia LO, Edwards J, et al
    Correlates of prevalent syphilis infection among men who have sex with men (MSM) living with HIV attending the HIV clinic in Trinidad.
    PLoS One. 2022;17:e0265909.
    PubMed         Abstract available

  39. ROJAS LJ, Yasmin M, Benjamino J, Marshall SM, et al
    Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing.
    PLoS One. 2022;17:e0265129.
    PubMed         Abstract available

  40. TAVOSCHI L, Belardi P, Mazzilli S, Manenti F, et al
    An integrated hospital-district performance evaluation for communicable diseases in low-and middle-income countries: Evidence from a pilot in three sub-Saharan countries.
    PLoS One. 2022;17:e0266225.
    PubMed         Abstract available

  41. SUN H, Wu G, Zhang J, Wang Y, et al
    Characterization of an intracellular humanized single-chain antibody to matrix protein (M1) of H5N1 virus.
    PLoS One. 2022;17:e0266220.
    PubMed         Abstract available

  42. CHRISTODOULOU J, Fehrenbacher AE, Shaw EH, Vincent EM, et al
    COVID-19 prevention behaviors, trust, and intent to vaccinate among youth at risk for HIV.
    PLoS One. 2022;17:e0266321.
    PubMed         Abstract available

  43. BIRHANU MY, Habtegiorgis SD, Gietaneh W, Alemu S, et al
    Magnitude and associated factors of urinary tract infections among adults living with HIV in Ethiopia. Systematic review and meta-analysis.
    PLoS One. 2022;17:e0264732.
    PubMed         Abstract available

  44. TURIMUMAHORO P, Tucker A, Gupta AJ, Tampi RP, et al
    A cost analysis of implementing mobile health facilitated tuberculosis contact investigation in a low-income setting.
    PLoS One. 2022;17:e0265033.
    PubMed         Abstract available

  45. IRIEMENAM NC, Ige FA, Greby SM, Mpamugo A, et al
    Validation of xMAP SARS-CoV-2 Multi-Antigen IgG assay in Nigeria.
    PLoS One. 2022;17:e0266184.
    PubMed         Abstract available

    PLoS Pathog

  46. CHANG XL, Reed JS, Webb GM, Wu HL, et al
    Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species.
    PLoS Pathog. 2022;18:e1010396.
    PubMed         Abstract available


  47. NANTHAPISAL S, Puthanakit T, Jaru-Ampornpan P, Nantanee R, et al
    A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines.
    Vaccine. 2022 Mar 24. pii: S0264-410X(22)00336.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.